A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity

Author(s):
Boer, P. de; Drevets, W.C.; Rofael, H.; Ark, P. van der; Kent, J.M.; Kezic, I.; Parapatics, S.; Dorffner, G.; Gerven, J. van; Benes, H.; Keicher, C.; Jahn, H.; Seiden, D.J.; Luthringer, R.
Published
2018
Publication type
Article / Letter to editor
Insomniaorexin antagonistssleep efficiencyseltorexantJNJ-42847922
Date issued
2018-06-30
Language
English
Is part of
Journal of Psychopharmacology (2018), Vol. 32, no. 6, p. 668-677
hdl
1887/96083
doi
10.1177/0269881118773745